Total Funding
85
68
Total FundingPre-Seed raised
Growth Score 85 in past quarter
-4 pts
Heat Score 68 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
126555
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions.
About the Company
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions, particularly diabetic peripheral neuropathic pain (DPNP). This condition affects a significant number of diabetics, with a lifetime incidence of about 50%, and is notoriously difficult to treat effectively with existing option